MADDALONI, ERNESTO
 Distribuzione geografica
Continente #
NA - Nord America 2.766
EU - Europa 800
AS - Asia 485
AF - Africa 26
OC - Oceania 13
SA - Sud America 11
Totale 4.101
Nazione #
US - Stati Uniti d'America 2.711
IT - Italia 395
SG - Singapore 237
SE - Svezia 203
IN - India 132
CN - Cina 95
CA - Canada 49
IE - Irlanda 26
UA - Ucraina 25
FI - Finlandia 21
RO - Romania 21
TG - Togo 21
DE - Germania 20
BG - Bulgaria 18
FR - Francia 18
GB - Regno Unito 16
AU - Australia 13
ES - Italia 7
AR - Argentina 6
MX - Messico 6
NL - Olanda 6
BE - Belgio 5
MY - Malesia 5
PL - Polonia 5
RU - Federazione Russa 4
SY - Repubblica araba siriana 4
CL - Cile 3
KR - Corea 3
TH - Thailandia 3
AL - Albania 2
AT - Austria 2
BR - Brasile 2
DK - Danimarca 2
HK - Hong Kong 2
IQ - Iraq 2
NG - Nigeria 2
PH - Filippine 2
ZA - Sudafrica 2
GR - Grecia 1
HU - Ungheria 1
LU - Lussemburgo 1
NO - Norvegia 1
TZ - Tanzania 1
Totale 4.101
Città #
Fairfield 527
Woodbridge 225
Seattle 209
Ashburn 197
Houston 189
Cambridge 175
Rome 174
Chandler 162
Wilmington 160
Singapore 150
Ann Arbor 86
Princeton 77
Millbury 68
Beijing 64
San Paolo di Civitate 58
Lawrence 57
San Diego 55
Plano 46
Ottawa 31
Santa Clara 31
Andover 26
Dublin 26
New York 26
Lomé 21
Sofia 18
Boston 17
Toronto 15
Norwalk 14
Stockholm 13
Boardman 12
Sydney 12
Milan 10
Des Moines 9
Helsinki 9
San Mateo 9
Dearborn 7
Madrid 7
Bühl 6
Induno Olona 6
Mannheim 6
Brussels 5
Federal 5
Fremont 5
Hefei 5
London 5
Los Angeles 5
Dallas 4
Messina 4
Venafro 4
Bangkok 3
Barrie 3
Chicago 3
Chieti 3
Gwanak-gu 3
Hebei 3
Lingolsheim 3
Mexico City 3
Molfetta 3
Nanjing 3
Naples 3
Southend 3
Târgu Mureş 3
Albuquerque 2
Arezzo 2
Bedong 2
Catanzaro 2
Copenhagen 2
Fontanellato 2
Fort Myers 2
Fort Worth 2
Guangzhou 2
Hong Kong 2
Hyderabad 2
Innsbruck 2
Ipoh 2
Johannesburg 2
Kirkuk 2
Kunming 2
Latina 2
Livorno 2
Menlo Park 2
Moscow 2
Nagpur 2
Nanchang 2
Pagani 2
Pomigliano d'Arco 2
Santarcangelo di Romagna 2
Shanghai 2
Termini Imerese 2
Tirana 2
Villaricca 2
Warsaw 2
Acton 1
Amsterdam 1
Bari 1
Beckenham 1
Boulder 1
Bremen 1
Brentford 1
Budapest 1
Totale 3.159
Nome #
Regional differences in milk and complementary feeding patterns in infants participating in an international nutritional type 1 diabetes prevention trial 109
Cardiometabolic multimorbidity is associated with a worse Covid-19 prognosis than individual cardiometabolic risk factors. A multicentre retrospective study (CoViDiab II) 103
Adult-onset autoimmune diabetes: current knowledge and implications for management 94
Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) 88
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetes 87
Impact of cardiovascular disease on clinical outcomes in hospitalized patients with Covid-19. a systematic review and meta-analysis 85
Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement 81
Wrist circumference is a biomarker of adipose tissue dysfunction and cardiovascular risk in children with obesity 81
Relation of Body Circumferences to Cardiometabolic Disease in Overweight-Obese Subjects 78
Frailty and geography: Should these two factors be added to the ABCDE contemporary guide to diabetes therapy? 76
Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity 74
Osteocalcin and sclerostin. Background characters or main actors in cardiovascular disease? 74
In vivo corneal confocal microscopy as a novel non-invasive tool to investigate cardiac autonomic neuropathy in Type 1 diabetes 72
New strategy to study the impact of ethnicity on diabetic neuropathy 70
Combination immunotherapies for type 1 diabetes mellitus 69
Diabetes-related autoantibodies in children with acute lymphoblastic leukemia 68
Comment on: "Early insulin treatment in type 2 diabetes: ORIGINal sin or valuable choice as ORIGINal treatment? An open debate on the ORIGIN study results" 67
Comparison of lipid-lowering medications and risk for cardiovascular disease in diabetes 67
Biomarkers of response to alpha-lipoic acid ± palmitoiletanolamide treatment in patients with diabetes and symptoms of peripheral neuropathy 66
Why China guidelines for type 2 diabetes represent an opportunity for treating this disease 66
Continuous glucose monitoring and robot surgery of an insulinoma: a case report and review of the literature 66
Effect of calcitriol on bone turnover and osteocalcin in recent-onset type 1 diabetes. 65
Buccal spray insulin (Oralgen) for type 2 diabetes: what evidence? 65
Chitotriosidase Activity Is Inversely Associated with Diastolic Blood Pressure and HbA1c but Not with Arterial Stiffness in Patients with Type 2 Diabetes without Complications 65
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodies 64
Bone Microarchitecture in Type 1 Diabetes: It Is Complicated 64
Long-term Risk of Cardiovascular Disease in Individuals with Latent Autoimmune Diabetes of Adults (UKPDS 85) 64
Bone health in subjects with type 1 diabetes for more than 50 years 62
Cardiovascular effects of SGLT-2 inhibitors: what we have learned from cardiovascular outcome trials and what we still need to understand 61
High Prevalence of Autoimmune Diabetes and Poor Glycaemic Control among Adults in Madagascar: A Brief Report from a Humanitarian Health Campaign in Ambanja 61
The complex combination of COVID-19 and diabetes: pleiotropic changes in glucose metabolism 61
Why only macro and not micro in type 2 diabetes? Time to change the goals of clinical trials in diabetes 60
Adult-onset autoimmune diabetes in 2020: an update 60
Effects of the COVID-19 lockdown on glycaemic control in subjects with type 2 diabetes: the glycalock study 59
Severe hypophosphatemic osteomalacia secondary to fanconi syndrome due to adefovir: A case report 58
SMART diabetes: the way to go (Safe and Multifactorial Approach to reduce the Risk for Therapy in diabetes) 58
Risk factors for fragility fractures in type 1 diabetes 58
PTH(1-34) for Surgical Hypoparathyroidism: A Prospective, Open-Label Investigation of Efficacy and Quality of Life 58
Glycemic Variability Assessed by Continuous Glucose Monitoring and Short-Term Outcome in Diabetic Patients Undergoing Percutaneous Coronary Intervention: An Observational Pilot Study 57
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes 57
Vitamin D and Diabetes Mellitus 57
Prevention of atherothrombotic events in patients with diabetes mellitus. From antithrombotic therapies to new-generation glucose-lowering drugs 57
Diabetes: the disease of the 10 D 57
Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules 57
Decrease of coronary heart disease risk with GLP1-receptor agonists or SGLT2 inhibitors therapy in patients with type 2 diabetes in primary cardiovascular prevention: a 24 months follow-up study 57
Treatment of reactive hypoglycemia with the macrobiotic Ma-pi 2 diet as assessed by continuous glucose monitoring: The MAHYP randomized crossover trial 54
Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function 54
Lifestyle Management of Diabetes: Implications for the Bone-Vascular Axis 53
Correction to: "H" for heterogeneity in the algorithm for type 2 diabetes management 53
Insulin decreases atherosclerosis by inducing endothelin receptor B expression 52
Risk of cardiac autonomic neuropathy in latent autoimmune diabetes in adults is similar to type 1 diabetes and lower compared to type 2 diabetes. A cross-sectional study 49
Association of osteocalcin, osteoprotegerin, and osteopontin with cardiovascular disease and retinopathy in type 2 diabetes 47
In vivo corneal confocal microscopy in diabetes: Where we are and where we can get 47
Platelet effects of anti-diabetic therapies: new perspectives in the management of patients with diabetes and cardiovascular disease 47
Serum 25-OH Vitamin D in relation to Bone Mineral Density and Bone Turnover 46
New technologies aiding dietary programmes for weight control: the oral glucose spray 45
Short-term safety profile of Sars-Cov2 vaccination on glucose control. Continuous glucose monitoring data in people with autoimmune diabetes 45
Diastolic Pressure And Acr Are Modifiable Risk Factors Of Arterial Stiffness In T2DM Without Cardiovascular Disease 42
Effects of covid-19 lockdown on glucose control: continuous glucose monitoring data from people with diabetes on intensive insulin therapy 40
Ischemic and bleeding risk by type 2 diabetes clusters in patients with acute coronary syndrome 40
C-peptide determination in the diagnosis of type of diabetes and its management: A clinical perspective 39
null 38
Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86) 38
Effectiveness and safety of calcium and vitamin D treatment for postmenopausal osteoporosis 37
Association of bone biomarkers with advanced atherosclerotic disease in people with overweight/obesity 37
Development of a clinical risk score to predict death in patients with COVID-19 37
Risk factors and predictive biomarkers of early cardiovascular disease in obese youth 36
Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths 36
Implementing the treatment of heart failure with SGLT-2 inhibitors and sacubitril-valsartan: does money matter? 34
The sodium–glucose co-transporter-2 (SGLT2) inhibitors reduce platelet activation and thrombus formation by lowering NOX2-related oxidative stress: a pilot study 32
Covid-19 and diabetes mellitus: unveiling the interaction of two pandemics 32
Reduced early response to SARS-CoV2 vaccination in people with type 1 and type 2 diabetes, a six months follow-up study. The CoVaDiab study I 28
Investigational therapies targeting CD3 for prevention and treatment of type 1 diabetes 28
Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status 28
Adult-onset autoimmune diabetes 27
Ranolazine Improves Glycemic Variability and Endothelial Function in Patients with Diabetes and Chronic Coronary Syndromes: Results from an Experimental Study 24
Il ruolo del biostatistico nella preparazione conduzione e monitoraggio delle sperimentazioni cliniche 22
Tipo 1 e LADA in crescita: prevenzione e assistenza ottimale 22
The vicious circle of left ventricular dysfunction and diabetes: from pathophysiology to emerging treatments 22
SGLT-2 inhibitors on top of current pharmacological treatments for heart failure: a comparative review on outcomes and cost effectiveness 22
Glycemic Variability in Subjects with Diabetes and Hypogonadism during Testosterone Replacement Treatment. A Pilot Study 19
Immune checkpoint modulators in early clinical development for the treatment of type 1 diabetes 19
null 17
Saxagliptin/dapagliflozin is non‐inferior to insulin glargine in terms of β‐cell function in subjects with latent autoimmune diabetes in adults: a 12‐month, randomized, comparator‐controlled pilot study 17
Editorial: The Changing Panorama of Diabetes Outcomes: Novel Complications and Novelties in Classical Complication 15
Lack of Association between Serum Chitotriosidase Activity and Arterial Stiffness in Type 2 Diabetes without Cardiovascular Complications 14
Serum chitotriosidase in postmenopausal women with severe osteoporosis 12
No differences in kidney function decline between people with type 2 diabetes starting a sodium-glucose cotransporter 2 inhibitor or a glucagon-like peptide-1 receptor agonist: a real-world retrospective comparative observational study 11
Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study 9
Impact of baseline kidney function on the effects of sodium-glucose co-transporter-2 inhibitors on kidney and heart failure outcomes: A systematic review and meta-analysis of randomized controlled trials 9
Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA 8
Updates on Glycaemic Control Strategies: A Range of Opportunities after Total Pancreatectomy 8
Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules 6
Relationship between Muscle Mass, Bone Density and Vascular Calcifications in Elderly People with SARS-CoV-2 Pneumonia 5
Obesity in type 1 diabetes: an overlooked immune-metabolic issue 5
Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes the TRIGR randomized clinical trial 4
Serum chitotriosidase in postmenopausal women with severe osteoporosis 3
Questions and answers on the use of aspirin for primary prevention of cardiovascular disease in diabetes 2
Endothelial Cells Induced Progenitors Into Brown Fat to Reduce Atherosclerosis 2
Growth and development of islet autoimmunity and type 1 diabetes in children genetically at risk 2
Totale 4.603
Categoria #
all - tutte 14.552
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.552


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020801 0 0 0 47 105 100 130 124 109 79 59 48
2020/2021700 48 34 33 18 7 38 13 19 73 171 128 118
2021/2022851 13 16 47 54 109 49 34 77 85 67 162 138
2022/2023899 178 170 66 94 58 92 28 68 60 25 45 15
2023/2024479 35 38 13 25 48 61 18 25 7 80 55 74
2024/2025236 33 88 107 8 0 0 0 0 0 0 0 0
Totale 4.604